Expert NetworkExpert InterviewBMY

Slingshot members are talking to an expert! The topic is:

Discussing Bristol-Myers Squibb's PAISLEY Phase II PRO Data on Deucravacitinib as a Treatment for Systemic Lupus Erythematosus (SLE)

Executed on:Sep 16, 2025 2:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: University of Washington
  • Clinical Associate Professor in Rheumatology at the University of Washington.
  • Treats 50 patients with psoriatic arthritis
  • Research focuses on studying biomarkers to assess autoimmune, rheumatic diseases and developing new treatment options for inflammatory conditions refractory to current standard therapy.

Interview Goal

To gain a deeper understanding of Deucravacitinib as a potential treatment for systemic lupus erythematosus (SLE)

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.